SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-005591
Filing Date
2021-01-20
Accepted
2021-01-20 06:05:08
Documents
25
Period of Report
2021-01-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213636d1_8k.htm 8-K 18974
2 EXHIBIT 99.1 tm213636d1_ex99-1.htm EX-99.1 31545
3 EXHIBIT 99.2 tm213636d1_ex99-2.htm EX-99.2 10242
4 GRAPHIC image_001.jpg GRAPHIC 317067
5 GRAPHIC image_002.jpg GRAPHIC 505013
6 GRAPHIC image_003.jpg GRAPHIC 226495
7 GRAPHIC image_004.jpg GRAPHIC 253476
8 GRAPHIC image_005.jpg GRAPHIC 269902
9 GRAPHIC image_006.jpg GRAPHIC 225682
10 GRAPHIC image_007.jpg GRAPHIC 204050
11 GRAPHIC image_008.jpg GRAPHIC 154943
12 GRAPHIC image_009.jpg GRAPHIC 87989
13 GRAPHIC image_010.jpg GRAPHIC 195065
14 GRAPHIC image_011.jpg GRAPHIC 244170
15 GRAPHIC image_012.jpg GRAPHIC 220407
16 GRAPHIC image_013.jpg GRAPHIC 248507
17 GRAPHIC image_014.jpg GRAPHIC 237885
18 GRAPHIC image_015.jpg GRAPHIC 208414
19 GRAPHIC image_016.jpg GRAPHIC 206781
20 GRAPHIC image_017.jpg GRAPHIC 226533
21 GRAPHIC image_018.jpg GRAPHIC 310404
22 GRAPHIC image_019.jpg GRAPHIC 230899
23 GRAPHIC image_020.jpg GRAPHIC 142412
24 GRAPHIC image_021.jpg GRAPHIC 48233
25 GRAPHIC image_022.jpg GRAPHIC 5471
  Complete submission text file 0001104659-21-005591.txt   6633613
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39788 | Film No.: 21537356
SIC: 2834 Pharmaceutical Preparations